Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14228597 | 0.96 | ALOX5 (0.34) | ALOX5DPP4 | |
| SCHEMBL8767030 | 0.90 | ALDH1A1 (0.33) | ALOX5 | |
| SCHEMBL13557300 | 0.89 | ALDH1A1 (0.32) | ALOX5DPP4 | |
| SCHEMBL20083481 | 0.85 | KMO (0.31) | DPP4 | |
| SCHEMBL14228603 | 0.84 | ESR2 (0.33) | — | |
| SCHEMBL6456852 | 0.84 | ESR2 (0.34) | — | |
| SCHEMBL6456856 | 0.84 | ESR2 (0.34) | — | |
| SCHEMBL17827799 | 0.84 | CES2 (0.31) | — | |
| SCHEMBL10018741 | 0.82 | ESR2 (0.31) | — | |
| SCHEMBL6455709 | 0.82 | ESR2 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11739267-B2 | LC medium | MERCK PATENT GMBH (DE) | 2023-08-29 | — | — | US | disclosed |
| US-11718791-B2 | Polymerisable compounds and the use thereof in liquid-crystal displays | MERCK PATENT GMBH (DE) | 2023-08-08 | — | — | US | disclosed |
| US-20230007940-A1 | LIQUID-CRYSTAL MEDIUM COMPRISING POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS | MERCKP PATENT GMBH (DE) | 2023-01-12 | — | — | US | disclosed |
| US-11008514-B2 | Liquid crystal medium | MERCK PATENT GMBH (DE) | 2021-05-18 | — | — | US | disclosed |
| US-20210139781-A1 | POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS | MERCK PATENT GMBH (DE) | 2021-05-13 | — | — | US | disclosed |
| US-20210087469-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2021-03-25 | — | — | US | disclosed |
| US-20210024826-A1 | LIQUID-CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2021-01-28 | — | — | US | disclosed |
| US-20200407640-A1 | LC MEDIUM | MERCK PATENT GMBH (DE) | 2020-12-31 | — | — | US | disclosed |
| US-20200263091-A1 | POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS | MERCK PATENT GMBH (DE) | 2020-08-20 | — | — | US | disclosed |
| US-10738240-B2 | Thiadiazoloquinoxaline derivatives | MERCK PATENT GMBH (DE) | 2020-08-11 | — | — | US | disclosed |
| US-10457871-B2 | Compounds and liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2019-10-29 | — | — | US | disclosed |
| US-20180223187-A1 | LIQUID CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2018-08-09 | — | — | US | disclosed |
| US-20180142153-A1 | THIADIAZOLOQUINOXALINE DERIVATIVES | MERCK PATENT GMBH (DE) | 2018-05-24 | — | — | US | disclosed |
| US-9944416-B2 | Filling device and use thereof for dispensing a fluid | MERCK PATENT GMBH (DE) | 2018-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11718791-B2 | Polymerisable compounds and the use thereof in liquid-crystal displays | VCL, ILK, LCP1 | ALOX5 1504/4885DPP4 2592/4885 |
| US-20210139781-A1 | POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS | VCL, ILK, LCP1 | ALOX5 1504/4885DPP4 2592/4885 |
| US-10457871-B2 | Compounds and liquid-crystalline medium | XDH, MLX, CXCR1 | ALOX5 2029/4885DPP4 3844/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.